Why repurposing drugs for MS can’t be rushed

siliconrepublic.com/innovation/ucd-research-repurposing-drugs-ms-leukaemia-alemtuzumab-safety

UCD’s Aradhika Patnaik believes that the best researchers value evidence over expediency.
Read more: Why repurposing drugs for MS can’t be rushed

This story appeared on siliconrepublic.com, 2025-06-10 06:00:28.
The Entire Business World on a Single Page. Free to Use →